Dacetuzumab Uses, Dosage, Side Effects and more
Dacetuzumab has been used in trials studying the treatment of Multiple Myeloma, Non-Hodgkin Lymphoma, Leukemia, Lymphocytic, Chronic, and Lymphoma, Large B-Cell, Diffuse. It is a humanized anti-CD40 antibody and induces cytotoxicity in human multiple myeloma cells.
| Attribute | Details |
|---|---|
| Trade Name | Dacetuzumab |
| Generic | Dacetuzumab |
| Dacetuzumab Other Names | Dacetuzumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in lymphoma (non-hodgkin's) and multiple myeloma.
